Cargando…

An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients

Although novel drugs and treatments have been developed and improved, multiple myeloma (MM) is still recurrent and difficult to cure. In the present study, the magenta module containing 400 hub genes was determined from the training dataset of GSE24080 through weighted gene co-expression network ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Linxin, Qu, Jian, Dai, Yuxin, Qi, Tingting, Teng, Xinqi, Li, Guohua, Qu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351694/ https://www.ncbi.nlm.nih.gov/pubmed/34260414 http://dx.doi.org/10.18632/aging.203294

Ejemplares similares

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
por: Qi, Tingting, et al.
Publicado: (2020)

A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature
por: Ji, Dexiang, et al.
Publicado: (2022)

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
por: Walker, Brian A, et al.
Publicado: (2015)

Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma
por: Zhao, Na, et al.
Publicado: (2023)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
por: Gao, Dandan, et al.
Publicado: (2023)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)

An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature
por: Yu, Zhengyu, et al.
Publicado: (2022)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
por: Ye, Dingde, et al.
Publicado: (2021)

Identification of hub methylated‐CpG sites and associated genes in oral squamous cell carcinoma
por: Dai, Yuxin, et al.
Publicado: (2020)

Molecular signatures of multiple myeloma progression through single cell RNA-Seq
por: Jang, Jin Sung, et al.
Publicado: (2019)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma
por: Zhu, Fang-xiao, et al.
Publicado: (2019)

An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma
por: Zhang, Shuai, et al.
Publicado: (2023)

Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma
por: Li, Tingting, et al.
Publicado: (2023)

Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022)

Pathogenesis and treatment of multiple myeloma
por: Yang, Peipei, et al.
Publicado: (2022)

A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma
por: Lu, Zhuangzhuang, et al.
Publicado: (2022)

Construction of a web‐based dynamic nomogram for predicting the prognosis in acute heart failure
por: Gao, Rongrong, et al.
Publicado: (2023)

Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
por: Martello, M., et al.
Publicado: (2022)

The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020)

Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy
por: Costacurta, Matteo, et al.
Publicado: (2021)

Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma
por: Xia, Yuren, et al.
Publicado: (2021)

Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
por: Xiang, Jing, et al.
Publicado: (2022)

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
por: Wan, Gang, et al.
Publicado: (2017)

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use
por: van Laar, Ryan, et al.
Publicado: (2014)

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma
por: Li, Licheng, et al.
Publicado: (2022)

Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
por: Soliman, Amro M., et al.
Publicado: (2021)

Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
por: Fu, Lin, et al.
Publicado: (2020)

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021)

Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021)

Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era
por: Zhou, Huixing, et al.
Publicado: (2023)

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

A Network Analysis of Multiple Myeloma Related Gene Signatures
por: Liu, Yu, et al.
Publicado: (2019)

Carbamazepine and Multiple Myeloma: Possible Interaction
por: Günaldı, Meral, et al.
Publicado: (2013)

Molecularly Targeted Therapies in Multiple Myeloma
por: de la Puente, Pilar, et al.
Publicado: (2014)

Editorial: Molecular Mechanisms of Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
por: Lee, Byung-Hyun, et al.
Publicado: (2020)

A nomogram to predict prognosis in Ewing sarcoma of bone
por: Zhou, Qiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hdiqgibmpj91kjbca7lo5dg55q